Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
22 studies found for:    Urokinase-type plasminogen activator receptor
Show Display Options
Rank Status Study
1 Terminated Urokinase Plasminogen Activator Receptor in Abiraterone Treated Patients With Castration Resistant Prostate Cancer
Condition: Prostatic Neoplasms
Interventions: Drug: Abiraterone;   Drug: Prednisolone
2 Unknown  Soluble Urokinase Plasminogen Activator Receptor (suPAR) in Late-onset Neonatal Sepsis
Condition: Neonatal Sepsis
3 Completed Evaluation of a New Radiotracer (64Cu-DOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission Tomography
Conditions: Breast Cancer;   Prostate Cancer;   Urinary Bladder Cancer
Intervention: Other: Injection of 64Cu-DOTA-AE105
4 Completed Evaluation of a New Radiotracer (68Ga-NOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission Tomography
Conditions: Breast Cancer;   Prostate Cancer;   Urinary Bladder Cancer
Interventions: Drug: Injection of 68Ga-NOTA-AE105;   Device: Positron Emission Tomography scans
5 Recruiting uPAR-PET/MRI in Glioblastoma Multiforme
Condition: Glioblastoma Multiforme
Interventions: Drug: One injection of 68Ga-NOTA-AE105;   Device: PET/MRI
6 Completed Dietary Seaweed and Early Breast Cancer: A Randomized Trial
Condition: Seaweed Associated Changes in Healthy Subjects
Interventions: Other: Seaweed;   Other: Placebo;   Other: Placebo2
7 Recruiting suPAR in the Early Diagnosis of Acute Kidney Injury(AKI) After On-Pump Cardiac Surgery
Condition: Acute Kidney Injury
8 Recruiting A Prospective Controlled Study of Serum suPAR in the CsA-treated FSGS Patients
Condition: FSGS
9 Recruiting Prehospital Recognition and Identification of Unspecific Symptoms
Conditions: Serious Condition;   Morality
10 Recruiting Role of SLURP-1 in Melanoma and Melanoma Stem Cells
Condition: Melanoma;
11 Recruiting uPAR PET/CT in Radium-223-dichloride Treatment of Patients With Metastatic Castration-resistant Prostate Cancer
Conditions: Prostate Cancer Metastatic;   Bone Metastases
Interventions: Drug: Injection of PET tracer 68Ga-NOTA-AE105;   Device: PET/CT
12 Not yet recruiting Prostaglandin E2 Predicts the Outcome of Acute-on-chronic Liver Failure
Conditions: Acute-On-Chronic Liver Failure;   Cirrhosis and Chronic Liver Disease
13 Recruiting Clinical Evaluation of Novel Biomarkers in Patients With Septicemia
Conditions: Sepsis;   Bacteremia;   Fungemia
14 Active, not recruiting Combination of Serum Measurements of Molecular Biomarkers and Serum Protein Profiling Can be Used to Predict Which Patients Undergoing Prostatic Biopsy Will be Diagnosed With Cancer
Conditions: Prostate Cancer;   Elevated Prostate Specific Antigen (PSA)
Intervention: Other: serum specimens obtained will be utilized for proteomic profiling comprising MALDI-TOF MS, and serum biomarker assays.
15 Recruiting A Crossover Pilot Study of the Effect of Amiloride on Proteinuria
Condition: Proteinuria
Interventions: Drug: Amiloride;   Drug: Triamterene
16 Recruiting Effect of Upper Airway Stimulation on Vascular Function in Obstructive Sleep Apnea
Condition: Obstructive Sleep Apnea
Intervention: Device: Hypoglossal Nerve Stimulation Treatment Withdrawal
17 Recruiting Biological Aging, Medication, Malnutrition and Inflammation Among Acutely Ill and Healthy Elderly.
Conditions: Aging;   Polypharmacy;   Malnutrition;   Inflammation;   Emergency Service, Hospital
18 Recruiting Healing Hearts and Mending Minds in Older Adults Living With HIV
Conditions: HIV;   Cardiovascular Disease;   AIDS
Interventions: Behavioral: Let's Move Program;   Behavioral: Let's Flex Program;   Behavioral: Group Motivational Interviewing
19 Active, not recruiting Risk Stratification in Acute Care: The Meaning of suPAR Measurement in Triage
Conditions: Triage;   Risk Stratification With Biomarker
Intervention: Behavioral: suPAR measurement
20 Recruiting Phase II Trial: uPAR-PET/CT for Prognostication in Head- and Neck Cancer
Condition: Head and Neck Cancer
Intervention: Drug: 68Ga-NOTA-AE105

   Previous Page Studies Shown (1-20) Next Page (21-22) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.